 Heres a roundup of top developments in the biotech space over the last 24 hours.On a day when the three major averages shed over 4 in reaction to bleak forecasts concerning the COVID-19 pandemics impact, none of the Nasdaq- or NYSE-listed biotech stocks hit 52-week highs or lows.Stocks In 